Results
GoodRx Holdings Inc.
02/26/2026 | Press release | Distributed by Public on 02/26/2026 05:03
Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
We only have operations within the United States and therefore do not have any foreign currency exposure. We are
exposed to market risks in the ordinary course of our business, including the effects of interest rate changes.
Interest Rate Risk
Our exposureto market risk for changes in interest rates relates primarily to our debt arrangements with floating interest
rates and a rising interest rate environment will increase the amount of interest paid on these loans. A hypothetical 100 basis
point increase in interest rates would have increased our interest expense by $5.0 millionfor the year ended December 31,
2025.
Impact of Inflation
We do not believe that inflation has had a material effect on our business, results of operations, or financial condition.
Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such
higher costs. Our inability or failure to do so could harm our business, financial condition, and results of operations.
GoodRx Holdings Inc. published this content on February 26, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 26, 2026 at 11:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]